1. Home
  2. CERO vs STSS Comparison

CERO vs STSS Comparison

Compare CERO & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • STSS
  • Stock Information
  • Founded
  • CERO 2017
  • STSS 2017
  • Country
  • CERO United States
  • STSS United States
  • Employees
  • CERO N/A
  • STSS N/A
  • Industry
  • CERO
  • STSS Medical/Dental Instruments
  • Sector
  • CERO
  • STSS Health Care
  • Exchange
  • CERO Nasdaq
  • STSS Nasdaq
  • Market Cap
  • CERO 3.1M
  • STSS 3.3M
  • IPO Year
  • CERO N/A
  • STSS 2022
  • Fundamental
  • Price
  • CERO $0.59
  • STSS $4.57
  • Analyst Decision
  • CERO Strong Buy
  • STSS
  • Analyst Count
  • CERO 1
  • STSS 0
  • Target Price
  • CERO $11.00
  • STSS N/A
  • AVG Volume (30 Days)
  • CERO 4.2M
  • STSS 1.2M
  • Earning Date
  • CERO 05-27-2025
  • STSS 05-23-2025
  • Dividend Yield
  • CERO N/A
  • STSS N/A
  • EPS Growth
  • CERO N/A
  • STSS N/A
  • EPS
  • CERO N/A
  • STSS N/A
  • Revenue
  • CERO N/A
  • STSS N/A
  • Revenue This Year
  • CERO N/A
  • STSS N/A
  • Revenue Next Year
  • CERO N/A
  • STSS N/A
  • P/E Ratio
  • CERO N/A
  • STSS N/A
  • Revenue Growth
  • CERO N/A
  • STSS N/A
  • 52 Week Low
  • CERO $0.53
  • STSS $3.30
  • 52 Week High
  • CERO $147.00
  • STSS $5,445.00
  • Technical
  • Relative Strength Index (RSI)
  • CERO 36.01
  • STSS 29.92
  • Support Level
  • CERO $0.55
  • STSS $4.35
  • Resistance Level
  • CERO $0.62
  • STSS $4.81
  • Average True Range (ATR)
  • CERO 0.06
  • STSS 0.58
  • MACD
  • CERO -0.01
  • STSS 2.58
  • Stochastic Oscillator
  • CERO 7.74
  • STSS 12.96

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.

Share on Social Networks: